Clinical Trials Logo

Clinical Trial Summary

This study will explore the preliminary efficacy of multiple intra-articular injections of LRX712 by evaluating the ability of the drug to restore structural integrity of articular cartilage. Efficacy will be evaluated in the context of the systemic safety and local tolerability of the investigational drug.


Clinical Trial Description

The purpose of this study is to evaluate the safety, tolerability and preliminary efficacy of multiple intra-articular injections of LRX712 in the knee when treating patients with knee osteoarthritis of mild/moderate severity, in order to support the further clinical development. This study will also allow refinement of the systemic and local pharmacokinetics of LRX712 and the exploration of drug effects on biomarkers of cartilage breakdown and regeneration in OA patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04097379
Study type Interventional
Source Novartis
Contact
Status Active, not recruiting
Phase Phase 2
Start date July 20, 2020
Completion date February 18, 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01620541 - Comparing Ankle Fusion to Ankle Replacement
Completed NCT01577563 - Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS). N/A
Completed NCT02113410 - Effect of Chair Yoga on Elders With Osteoarthritis N/A
Terminated NCT04941729 - Study to Evaluate the Safety and Efficacy of OR3O™ Dual Mobility System vs. Conventional Single Bearing Design Total Hip System N/A
Completed NCT02726945 - Adipose-derived SVF for the Treatment of Knee OA N/A